| Title | Onkológia
|
|---|
| Year, No. | Roč. 17, č. 2, rok 2022
|
|---|
| ISSN | 1336-8176
|
|---|
| Issue data | Bratislava : SOLEN, 2022
|
|---|
| Phys.des. | s. 77-142
|
|---|
| Collective Record/Entry | Onkológia
|
|---|
| Language | Slovak
|
|---|
| Country | Slovakia
|
|---|
| Copy count | 2, currently available 0, at library only 2
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Onkologická starostlivosť vo vojnových oblastiach. Čo sme sa naučili? = Cancer care in war zones: vhat have we learnt? / / Peter Beržinec : zaujímavosti zo..
|
|---|
| Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central.. / Berzinec P. ... [et al.]
|
|---|
| Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic.. / Drgona L., Petrikova L. ... [et..
|
|---|
| Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor / / Drgona L. ... [et al.]
|
|---|
| Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia / / Drgona L. ... [et al.]
|
|---|
| Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer.. / Palacka P. ... [et al.]
|
|---|
| Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic.. / Salek T. ... [et al.]
|
|---|
| Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy / / Chovanec M. ... [et al.]
|
|---|
| Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients / / Kalavska K. ... [et al.]
|
|---|
| Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell.. / Schmidtova S. ... [et al.]
|
|---|
| ASCO Gastrointestinal Cancers 2022 / / Tomáš Šálek
|
|---|
| Metastáza malígneho melanómu imitujúca primárny nádor prsníka = Malignant melanoma metastasis mimicking a primary breast tumor / / Lenka Svobodová, Radovan Barila
|
|---|
| Trastuzumab deruxtecan - profil lieku a využitie v liečbe pokročilého HER-pozitívneho karcinómu prsníka = Trastuzumab deruxtecan - drug profile and use in the treatment.. / Radovan Barila, Lenka Svobodová,..
|
|---|
| Prínos ribociklibu v signifikant[n]om zlepšení celkového prežívania premenopauzálnych a postmenopauzálnych pacientok (žien) s HR-pozitívnym,.. Ribociclib significantly.. / Filip Kohútek, Branislav Bystrický
|
|---|
| Výživa a karcinóm prsníka = Nutrition and breast cancer / / Peter Minárik ... [et al.]
|
|---|
| Adjuvantná liečba melanómu v 3. štádiu po kompletnej resekcii = Adjuvant treatment of stage III melanoma after complete resection / / Silvia Jurišová
|
|---|
| Ako sa pozeráme na inhibítory CDK4/6 v paliatívnej liečbe dnes = How do we look at CDK4/6 inhibitors in palliative treatment today / / Miroslava Malejčíková
|
|---|
| Optimálny manažment pacientok s karcinómom prsníka po progresii na CDK4/6 inhibítoroch = Optimal management of patients with breast cancer after progression on CDK4/6.. / Filip Kohútek, Branislav Bystrický
|
|---|
| Postavenie PARP inhibítorov v liečbe karcinómu prsníka = The role of PARP inhibitors in the treatment of breast cancer / / Eliška Volochová, Marian Streško
|
|---|
| Komplexný pohľad na liečbu HER2-pozitívneho karcinómu prsníka = A comprehensive view of the treatment of HER2-positive breast cancer / / Bela Mriňáková
|
|---|
| Pokroky v liečbe nádorov prsníka / / Bibiána Vertáková-Krakovská
|
|---|
